Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Acutely Decompensated Heart Failure
2023-504165-23-00Phase 3Completed
- Sponsor
- Fundación para la Formación e Investigación Sanitaria
- Start
- Mar 2023
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in heart failure (HF) comparing Colchicine with Placebo (2 arms). Primary endpoint: Decreased NT-proBNP levels. Started Mar 2023; status: completed.
02
Drugs
colchicine
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2023-504165-23-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504165-23-00.